Pulmonary Disease Doctors in Urbana, IL Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Nishanth Vallumsetla, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1405 W Park St, Urbana, IL 61801 Phone: 507-284-2511

Ms. Victoria Oluwakemi Famuyide, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3190    Fax: 217-383-7117

Dr. Vishesh Paul, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park St., Pulmonary Medicine, Urbana, IL 61801 Phone: 217-383-3190    Fax: 217-383-7117

Donald A Greeley, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 602 W University Avenue, Pulmonary Medicine, Urbana, IL 61801 Phone: 217-383-3190    Fax: 217-383-7117

David M Main, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 611 W Park St, Pulmonary Medicine, Urbana, IL 61801 Phone: 217-383-3190    Fax: 217-383-7117

News Archive

Nonprofit group launches website that provides education, information about breast density

Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website. The site, www.DenseBreast-info.org, addresses questions women and their healthcare providers often have about breast density - helping them to "Get Smart about Being Dense."

Scientists uncover new layer of information in the genetic code

A hidden and never before recognized layer of information in the genetic code has been uncovered by a team of scientists at the University of California, San Francisco (UCSF) thanks to a technique developed at UCSF called ribosome profiling, which enables the measurement of gene activity inside living cells - including the speed with which proteins are made.

CAM314 randomized Phase 3 clinical trial results released

Genzyme Corporation announced data from its CAM314 randomized Phase 3 clinical trial comparing Campath (alemtuzumab) in combination with Fludara (fludarabine phosphate) (FluCAM) to Fludara alone in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) demonstrated that the FluCAM regimen significantly reduced the risk of disease progression or death compared to single-agent Fludara.

Foreign aid should enhance, not replace, domestic health spending in developing countries

A case in Uganda of a woman bleeding to death while giving birth "underscores an unintended consequence of global health aid," a Globe and Mail editorial writes, adding that "in some parts of sub-Saharan Africa, a reverse trend is under way; for every $1 of development assistance for health, governments have reduced their spending," according to a study from the Institute for Health Metrics and Evaluation at the University of Washington.

Read more Medical News

› Verified 4 days ago